Fuel-cell manufacturers including Plug Power Inc. that have been the top three Nasdaq gainers in the past month surged ahead of earnings reports this week that are expected to show them on the path toward profitability.
Zeltia SA, a Spanish company that develops cancer drugs from sea creatures, is considering a spinoff of its biotechnology unit to list it on the Nasdaq Stock Market, according to people familiar with the matter.
Money is flooding into exchange- traded funds focused on health care at the fastest rate in at least six years, driven by booming biotechnology and pharmaceutical sectors bringing new products to market.
China’s Tencent Holdings Ltd., the best-performing major technology stock worldwide in the past five years, is mirroring gains by the biggest U.S. computer companies at the height of the dot-com bubble.
This time last year, the chairman and chief executive officer of Israel’s Teva Pharmaceutical Industries Ltd., the world’s biggest generic drugmaker, were foreigners. Miami billionaire Phillip Frost led the board and Jeremy Levin, a South African, was CEO. They were the first non- Israelis to hold those positions.